Cardiogenesis Breaks Ground on Heart-Pumping New Research
Cardiogenesis, the clinical and market leader in transmyocardial revascularization (TMR), revealed this week that it has enrolled its first two patients for its feasibility study involving the cutting-edge PHOENIX System.